Seeley, requires additional metabolic benefits
A "plateau" on the scale doesn't mean the protocol stopped working
If someone is healthy and not obese, then the benefits are less, but the risks are the same
Sun Pharma has GL0034 (also called Utreglutide), an in-house GLP-1 molecule now in global Phase II trials for both Type 2 diabetes and MASH, a form of fatty liver disease
This is important, as you dont want to go too far in the wrong direction and send yourself into hyperthyroid, which has a whole other list of symptoms (including heart palpitations)
The peptide has also shown efficacy in experimental models of skeletal muscle injury, with studies demonstrating accelerated healing, reduced fibrosis, and improved functional recovery